{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:18:21Z","timestamp":1760242701885,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotoxicology and Teratology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ntt.2014.08.005","type":"journal-article","created":{"date-parts":[[2014,9,2]],"date-time":"2014-09-02T18:12:50Z","timestamp":1409681570000},"page":"91-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Genetic correlational analysis reveals no association between MPP+ and the severity of striatal dopaminergic damage following MPTP treatment in BXD mouse strains"],"prefix":"10.1016","volume":"45","author":[{"given":"Byron C.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"O'Callaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gelareh","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane B.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ntt.2014.08.005_bb0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainres.2007.07.067","article-title":"Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta","volume":"1175","author":"Boyd","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.ntt.2014.08.005_bb0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0006-8993(99)01273-1","article-title":"Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus","volume":"828","author":"Hamre","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.ntt.2014.08.005_bb0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuro.2013.03.010","article-title":"Systems analysis of genetic variation in MPTP neurotoxicity in mice","volume":"37","author":"Jones","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ntt.2014.08.005_bb0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.1998.tb08230.x","article-title":"The impact of gender and estrogen on striatal dopaminergic neurotoxicity","volume":"844","author":"Miller","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ntt.2014.08.005_bb0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/exnr.1994.1058","article-title":"Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57\/bl and CD-1 mice","volume":"126","author":"Muthane","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1016\/j.ntt.2014.08.005_bb0030","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1517\/14740338.4.3.433","article-title":"GFAP and other glial proteins as biomarkers of neurotoxicity","volume":"4","author":"O'Callaghan","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ntt.2014.08.005_bb0040","first-page":"228","article-title":"Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"117","author":"O'Callaghan","year":"1990","journal-title":"Brain Res"},{"issue":"7","key":"10.1016\/j.ntt.2014.08.005_bb0035","doi-asserted-by":"crossref","first-page":"e102003","DOI":"10.1371\/journal.pone.0102003","article-title":"Early activation of STAT3 regulates reactive astrogliosis induced by diverse forms of neurotoxicity","volume":"9","author":"O'Callaghan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ntt.2014.08.005_bb9880","doi-asserted-by":"crossref","first-page":"19936","DOI":"10.1074\/jbc.M309304200","article-title":"Activation of the gp130-JAK\/STAT3 pathway in astrocytes precedes the induction of GFAP in the MPTP model of dopaminergic neurodegeneration: Key signaling pathway for astrogliosis","volume":"279","author":"Sriram","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Neurotoxicology and Teratology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036214001597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036214001597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:20:57Z","timestamp":1760210457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892036214001597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":9,"alternative-id":["S0892036214001597"],"URL":"https:\/\/doi.org\/10.1016\/j.ntt.2014.08.005","relation":{},"ISSN":["0892-0362"],"issn-type":[{"type":"print","value":"0892-0362"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic correlational analysis reveals no association between MPP+ and the severity of striatal dopaminergic damage following MPTP treatment in BXD mouse strains","name":"articletitle","label":"Article Title"},{"value":"Neurotoxicology and Teratology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ntt.2014.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}